Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F9 | P00740 | 1/20 | 0.43 |
| ▸ | F10 | P00742 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.40 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.39 |
| ▸ | CYCS | P99999 | 4/20 | 0.38 |
| ▸ | TOP1 | P11387 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14599692 | 0.86 | FFAR1 (0.38) | F9F10KDM4EHSD17B10HPGD | |
| SCHEMBL8907605 | 0.84 | ABCG2 (0.52) | KDM4EHSD17B10HPGDALDH1A1TP53 | |
| SCHEMBL14599691 | 0.82 | PDE3B (0.41) | F9F10KDM4EHSD17B10HPGD | |
| SCHEMBL19718117 | 0.77 | CYSLTR2 (0.47) | PDE3BPDE3AP2RY12 | |
| SCHEMBL12057429 | 0.76 | NR5A1 (0.44) | ABCG2CYCSTOP1 | |
| SCHEMBL14599693 | 0.75 | F9 (0.36) | F9F10KDM4EHSD17B10HPGD | |
| SCHEMBL14599694 | 0.75 | F9 (0.37) | F9F10KDM4EHSD17B10HPGD | |
| SCHEMBL8908945 | 0.75 | ABCG2 (0.46) | ALDH1A1TP53MAPTPDE3BPDE3A | |
| SCHEMBL12646482 | 0.74 | KDM4E (0.57) | F9F10KDM4EHSD17B10HPGD | |
| SCHEMBL14599689 | 0.73 | ADORA2B (0.39) | F9F10KDM4EHSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070015742-A1 | Porphyrin derivatives | YAHIOGLU GOKHAN | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015742-A1 | Porphyrin derivatives | SCO2, CBR3, CBR1 | F9 1407/4885F10 612/4885KDM4E 3310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.